347 related articles for article (PubMed ID: 22522606)
1. Lipoteichoic acid of Bifidobacterium in combination with 5-fluorouracil inhibit tumor growth and relieve the immunosuppression.
Xie N; Wang Y; Wang Q; Li FR; Guo B
Bull Cancer; 2012 May; 99(5):E55-63. PubMed ID: 22522606
[TBL] [Abstract][Full Text] [Related]
2. Cooperative effect of Bifidobacteria lipoteichoic acid combined with 5-fluorouracil on hepatoma-22 cells growth and apoptosis.
Guo B; Xie N; Wang Y
Bull Cancer; 2015 Mar; 102(3):204-12. PubMed ID: 25747889
[TBL] [Abstract][Full Text] [Related]
3. CpG oligodeoxynucleotides inhibit tumor growth and reverse the immunosuppression caused by the therapy with 5-fluorouracil in murine hepatoma.
Wang XS; Sheng Z; Ruan YB; Guang Y; Yang ML
World J Gastroenterol; 2005 Feb; 11(8):1220-4. PubMed ID: 15754409
[TBL] [Abstract][Full Text] [Related]
4. Galactosylated chitosan/5-fluorouracil nanoparticles inhibit mouse hepatic cancer growth and its side effects.
Cheng MR; Li Q; Wan T; He B; Han J; Chen HX; Yang FX; Wang W; Xu HZ; Ye T; Zha BB
World J Gastroenterol; 2012 Nov; 18(42):6076-87. PubMed ID: 23155336
[TBL] [Abstract][Full Text] [Related]
5. [Changes of regulatory T cell number in hepatocellular carcinoma-bearing mice and its relationship with tumor growth].
Zhang P; Zhang LN; Zhu FL; Wang Q; Wang XY; Li HY; Liu CM; Gao F; Liu CH
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):342-5. PubMed ID: 17892128
[TBL] [Abstract][Full Text] [Related]
6. Tim-1 blockade with RMT1-10 increases T regulatory cells and prolongs the survival of high-risk corneal allografts in mice.
Tan X; Jie Y; Zhang Y; Qin Y; Xu Q; Pan Z
Exp Eye Res; 2014 May; 122():86-93. PubMed ID: 24613782
[TBL] [Abstract][Full Text] [Related]
7. Polysaccharides from Tricholoma matsutake and Lentinus edodes enhance 5-fluorouracil-mediated H22 cell growth inhibition.
Ren M; Ye L; Hao X; Ren Z; Ren S; Xu K; Li J
J Tradit Chin Med; 2014 Jun; 34(3):309-16. PubMed ID: 24992758
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
[TBL] [Abstract][Full Text] [Related]
9. [Effects of excreted/secreted antigens of Toxoplasma gondii on CD4+ CD25+ Foxp3+ T cells and NK cells of melanoma-bearing mice].
Jiao YM; Zhang L; Ge YY; Liang YJ; Yong W
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Jun; 23(3):301-6. PubMed ID: 22164498
[TBL] [Abstract][Full Text] [Related]
10. The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis.
Ju Y; Shang X; Liu Z; Zhang J; Li Y; Shen Y; Liu Y; Liu C; Liu B; Xu L; Wang Y; Zhang B; Zou J
Mol Immunol; 2014 Mar; 58(1):85-91. PubMed ID: 24333756
[TBL] [Abstract][Full Text] [Related]
11. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.
Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200
[TBL] [Abstract][Full Text] [Related]
12. TRAIL suppresses tumor growth in mice by inducing tumor-infiltrating CD4(+)CD25 (+) Treg apoptosis.
Diao Z; Shi J; Zhu J; Yuan H; Ru Q; Liu S; Liu Y; Zheng D
Cancer Immunol Immunother; 2013 Apr; 62(4):653-63. PubMed ID: 23143747
[TBL] [Abstract][Full Text] [Related]
13. Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells.
Ko K; Yamazaki S; Nakamura K; Nishioka T; Hirota K; Yamaguchi T; Shimizu J; Nomura T; Chiba T; Sakaguchi S
J Exp Med; 2005 Oct; 202(7):885-91. PubMed ID: 16186187
[TBL] [Abstract][Full Text] [Related]
14. The combination therapy of α-galactosylceramide and 5-fluorouracil showed antitumor effect synergistically against liver tumor in mice.
Aketa H; Tatsumi T; Kohga K; Tsunematsu H; Aono S; Shimizu S; Kodama T; Nawa T; Shigekawa M; Hikita H; Sakamori R; Hosui A; Miyagi T; Hiramatsu N; Kanto T; Hayashi N; Takehara T
Int J Cancer; 2013 Sep; 133(5):1126-34. PubMed ID: 23420533
[TBL] [Abstract][Full Text] [Related]
15. Osthole promotes anti-tumor immune responses in tumor-bearing mice with hepatocellular carcinoma.
Zhang L; Jiang G; Yao F; Liang G; Wang F; Xu H; Wu Y; Yu X; Liu H
Immunopharmacol Immunotoxicol; 2015 Jun; 37(3):301-7. PubMed ID: 25975579
[TBL] [Abstract][Full Text] [Related]
16. Combination of SLC administration and Tregs depletion is an attractive strategy for targeting hepatocellular carcinoma.
Chen L; Zhou S; Qin J; Hu H; Ma H; Liu B; Wang X; Ma J; Ye S; Zhong C; Zhou G; Liang C
Mol Cancer; 2013 Dec; 12(1):153. PubMed ID: 24304581
[TBL] [Abstract][Full Text] [Related]
17. The potential effect and mechanism of high-mobility group box 1 protein on regulatory T cell-mediated immunosuppression.
Zhang Y; Yao YM; Huang LF; Dong N; Yu Y; Sheng ZY
J Interferon Cytokine Res; 2011 Feb; 31(2):249-57. PubMed ID: 21087077
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
[TBL] [Abstract][Full Text] [Related]
19. Purification of a polysaccharide from Boschniakia rossica and its synergistic antitumor effect combined with 5-Fluorouracil.
Wang Z; Wu B; Zhang X; Xu M; Chang H; Lu X; Ren X
Carbohydr Polym; 2012 Jun; 89(1):31-5. PubMed ID: 24750599
[TBL] [Abstract][Full Text] [Related]
20. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
Ghiringhelli F; Ménard C; Terme M; Flament C; Taieb J; Chaput N; Puig PE; Novault S; Escudier B; Vivier E; Lecesne A; Robert C; Blay JY; Bernard J; Caillat-Zucman S; Freitas A; Tursz T; Wagner-Ballon O; Capron C; Vainchencker W; Martin F; Zitvogel L
J Exp Med; 2005 Oct; 202(8):1075-85. PubMed ID: 16230475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]